• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

西非的埃博拉病毒以及实验性疗法或疫苗的使用。

Ebolavirus in West Africa, and the use of experimental therapies or vaccines.

作者信息

Hoenen Thomas, Feldmann Heinz

出版信息

BMC Biol. 2014 Sep 26;12:80. doi: 10.1186/s12915-014-0080-6.

DOI:10.1186/s12915-014-0080-6
PMID:25286348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4177057/
Abstract

Response to the current ebolavirus outbreak based on traditional control measures has so far been insufficient to prevent the virus from spreading rapidly. This has led to urgent discussions on the use of experimental therapies and vaccines untested in humans and existing in limited quantities, raising political, strategic, technical and ethical questions.

摘要

基于传统控制措施对当前埃博拉病毒爆发的应对迄今不足以阻止病毒迅速传播。这引发了关于使用未经人体试验且数量有限的实验性疗法和疫苗的紧急讨论，提出了政治、战略、技术和伦理问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b418/4177057/11fae93637b0/12915_2014_80_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b418/4177057/161db17b54f5/12915_2014_80_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b418/4177057/11fae93637b0/12915_2014_80_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b418/4177057/161db17b54f5/12915_2014_80_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b418/4177057/11fae93637b0/12915_2014_80_Fig2_HTML.jpg

相似文献

1
Ebolavirus in West Africa, and the use of experimental therapies or vaccines.西非的埃博拉病毒以及实验性疗法或疫苗的使用。
BMC Biol. 2014 Sep 26;12:80. doi: 10.1186/s12915-014-0080-6.
2
Ebola treatments caught in limbo.埃博拉治疗陷入困境。
Nature. 2014 Jul 31;511(7511):520. doi: 10.1038/511520a.
3
Ebola virus disease: a highly fatal infectious disease reemerging in West Africa.埃博拉病毒病：一种在西非再度出现的高度致命性传染病。
Microbes Infect. 2015 Feb;17(2):84-97. doi: 10.1016/j.micinf.2014.11.007. Epub 2014 Nov 29.
4
Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us.美国应对严重传染病的准备：埃博拉病毒疫情给我们的教训。
Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0011-2016.
5
Scale up the supply of experimental Ebola drugs.扩大实验性埃博拉药物的供应。
Nature. 2014 Aug 21;512(7514):233. doi: 10.1038/512233a.
6
The Ebola outbreak in West Africa: a story of related public health challenges and a pointer to solutions to mitigate the inevitable next outbreak.西非埃博拉疫情：一系列相关公共卫生挑战的故事以及减轻下一次不可避免疫情爆发的解决方法指南。
Pan Afr Med J. 2014 Sep 22;19:48. doi: 10.11604/pamj.2014.19.48.5336. eCollection 2014.
7
The Ebola endgame, and what comes after.埃博拉的终局，以及之后会发生什么。
Lancet Infect Dis. 2015 Jun;15(6):615. doi: 10.1016/S1473-3099(15)00032-8. Epub 2015 May 17.
8
[Ebola : an uncontrolled outbreak despite vaccines and new treatments].[埃博拉：尽管有疫苗和新疗法，但疫情仍失控]
Rev Med Suisse. 2020 Apr 15;16(690):739-743.
9
Ebolavirus Evolution: Past and Present.埃博拉病毒的进化：过去与现在
PLoS Pathog. 2015 Nov 12;11(11):e1005221. doi: 10.1371/journal.ppat.1005221. eCollection 2015.
10
[Ebola vaccine and treatment].[埃博拉疫苗与治疗]
Uirusu. 2015;65(1):61-70. doi: 10.2222/jsv.65.61.

引用本文的文献

1
One-step single-tube accelerated quantitative nucleoprotein gene-specific reverse transcription loop-mediated isothermal gene amplification (RT-LAMP) assay for rapid, real-time & reliable clinical detection of Ebola virus.一步单管加速定量核蛋白基因特异性逆转录环介导等温基因扩增 (RT-LAMP) 检测法，用于快速、实时和可靠的埃博拉病毒临床检测。
Indian J Med Res. 2021 Apr;154(4):598-606. doi: 10.4103/ijmr.IJMR_864_19.
2
Therapeutic strategies to target the Ebola virus life cycle.针对埃博拉病毒生命周期的治疗策略。
Nat Rev Microbiol. 2019 Oct;17(10):593-606. doi: 10.1038/s41579-019-0233-2. Epub 2019 Jul 24.
3
Modeling the Ebola zoonotic dynamics: Interplay between enviroclimatic factors and bat ecology.

本文引用的文献

1
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.黑猩猩腺病毒疫苗可产生针对埃博拉病毒挑战的急性和持久保护免疫。
Nat Med. 2014 Oct;20(10):1126-9. doi: 10.1038/nm.3702. Epub 2014 Sep 7.
2
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.ZMapp 逆转非人灵长类动物的晚期埃博拉病毒病。
Nature. 2014 Oct 2;514(7520):47-53. doi: 10.1038/nature13777. Epub 2014 Aug 29.
3
Reverse genetics systems as tools for the development of novel therapies against filoviruses.
埃博拉人畜共患病动力学建模：环境气候因素与蝙蝠生态学之间的相互作用
PLoS One. 2017 Jun 12;12(6):e0179559. doi: 10.1371/journal.pone.0179559. eCollection 2017.
4
Health-Care Workers' Perspectives on Ebola Virus Vaccine: A Focus Group and In-Depth Interview Interventional Study.医护人员对埃博拉病毒疫苗的看法：一项焦点小组和深入访谈干预性研究。
Am J Trop Med Hyg. 2016 Sep 7;95(3):654-62. doi: 10.4269/ajtmh.16-0206. Epub 2016 Jul 5.
5
Cell-cell contact promotes Ebola virus GP-mediated infection.细胞间接触促进埃博拉病毒糖蛋白介导的感染。
Virology. 2016 Jan 15;488:202-15. doi: 10.1016/j.virol.2015.11.019. Epub 2015 Dec 3.
6
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers.使用通用他汀类药物和血管紧张素受体阻滞剂治疗宿主对埃博拉病毒病的反应。
mBio. 2015 Jun 23;6(3):e00716. doi: 10.1128/mBio.00716-15.
7
Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative.埃博拉研究中基础、临床和专利知识的霸权结构：美国陆军的还原论倡议。
J Transl Med. 2015 Apr 19;13:124. doi: 10.1186/s12967-015-0496-y.
8
Global Access Programs: A Collaborative Approach for Effective Implementation and Management.全球准入计划：有效实施与管理的协作方法
Pharmaceut Med. 2015;29(2):79-85. doi: 10.1007/s40290-015-0091-9.
9
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.西非的人类埃博拉病毒感染：针对埃博拉病毒生命周期不同阶段的可用治疗药物综述
Infect Dis Poverty. 2014 Nov 28;3:43. doi: 10.1186/2049-9957-3-43. eCollection 2014.
反向遗传学系统作为开发抗丝状病毒新疗法的工具。
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1253-63. doi: 10.1586/14787210.2014.948848. Epub 2014 Aug 28.
4
Largest-ever outbreak of Ebola virus disease thrusts experimental therapies, vaccines into spotlight.有史以来最大规模的埃博拉病毒病疫情将实验性疗法和疫苗推到了聚光灯下。
JAMA. 2014 Sep 10;312(10):987-9. doi: 10.1001/jama.2014.11170.
5
Post-exposure therapy of filovirus infections.丝状病毒感染的暴露后治疗。
Trends Microbiol. 2014 Aug;22(8):456-63. doi: 10.1016/j.tim.2014.04.002. Epub 2014 Apr 30.
6
Emergence of Zaire Ebola virus disease in Guinea.刚果（金）埃博拉疫情在几内亚出现。
N Engl J Med. 2014 Oct 9;371(15):1418-25. doi: 10.1056/NEJMoa1404505. Epub 2014 Apr 16.
7
mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.当在检测到病毒血症和症状后给予单克隆抗体和腺载体 IFN-α 治疗时，可挽救感染埃博拉病毒的非人灵长类动物。
Sci Transl Med. 2013 Oct 16;5(207):207ra143. doi: 10.1126/scitranslmed.3006605.
8
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.用 MB-003 单克隆抗体鸡尾酒疗法治疗恒河猴的埃博拉病毒感染。
Sci Transl Med. 2013 Aug 21;5(199):199ra113. doi: 10.1126/scitranslmed.3006608.
9
Potential vaccines and post-exposure treatments for filovirus infections.丝状病毒感染的潜在疫苗和暴露后治疗方法。
Viruses. 2012 Sep;4(9):1619-50. doi: 10.3390/v4091619. Epub 2012 Sep 21.
10
Flexibility of mobile laboratory unit in support of patient management during the 2007 Ebola-Zaire outbreak in the Democratic Republic of Congo.移动实验室单元的灵活性在支持 2007 年刚果民主共和国埃博拉-扎伊尔疫情期间的患者管理中的作用。
Zoonoses Public Health. 2012 Sep;59 Suppl 2:151-7. doi: 10.1111/j.1863-2378.2012.01477.x.